Metformin Alkaloid

Metformin Hydrochloride, the active ingredient in Metformin Alkaloid, is a biguanide presented as an oral dosage form for oral use. It is employed to lower blood glucose levels in adults with type 2 diabetes mellitus by decreasing hepatic glucose output and improving peripheral insulin sensitivity, thereby supporting overall glycaemic control.

GNH USA supplies Metformin Alkaloid as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Metformin Hydrochloride is indicated for conditions affecting glucose metabolism and insulin resistance.

- Type 2 diabetes mellitus: improves glycaemic control by reducing fasting and post‑prandial glucose levels. - Prediabetes (impaired glucose tolerance): delays progression to overt diabetes through modest glucose‑lowering effects. - Gestational diabetes mellitus: adjunct to diet when glycaemic targets are not met, helping to maintain maternal blood sugar within recommended ranges.

Metformin Hydrochloride may cause a range of adverse reactions, from mild to serious.

Common Side Effects: - Nausea: transient gastrointestinal upset. - Diarrhea: loose stools, often early in therapy. - Abdominal discomfort: cramping or bloating. - Metallic taste: temporary alteration in taste perception. - Loss of appetite: reduced desire to eat. - Vitamin B12 deficiency: long‑term use may lower B12 levels.

Serious or Rare Side Effects: - Lactic acidosis: rare but life‑threatening metabolic acidosis. - Severe hypoglycaemia: usually when combined with other glucose‑lowering agents. - Hepatotoxicity: abnormal liver function tests. - Severe skin reactions: such as Stevens‑Johnson syndrome. - Acute pancreatitis: inflammation of the pancreas. - Persistent gastrointestinal bleeding: uncommon but serious.

Metformin Hydrochloride requires careful assessment before initiation and during therapy.

- Renal function: assess creatinine clearance; avoid if severe impairment. - Hepatic disease: use with caution; monitor liver enzymes. - Cardiovascular status: consider in patients with unstable heart failure. - Alcohol consumption: limit intake to reduce risk of lactic acidosis. - Pregnancy and lactation: evaluate risk‑benefit; consult obstetric guidance. - Store at ambient temperature: keep below 25 °C, in original packaging, protected from moisture and light.

Metformin Hydrochloride can interact with several medicines, altering its efficacy or safety.

Major Interactions (Avoid): - Iodinated contrast agents: risk of acute renal failure and lactic acidosis. - Cimetidine: may increase metformin plasma concentrations. - Certain antiretrovirals (e.g., didanosine): heightened risk of lactic acidosis.

Moderate Interactions (Monitor Closely): - Diuretics: can affect renal clearance of metformin. - Beta‑blockers: may mask hypoglycaemia symptoms. - ACE inhibitors/ARBs: monitor renal function and electrolytes. - NSAIDs: may impair renal function, increasing metformin exposure.